Relief Therapeutics and NeuroRx, Inc. File FDA IND for Aviptadil
to Treat COVID-19-induced Respiratory Distress

  1. Pallaskorpi, et al. “Incidence and predictors of suicide attempts in bipolar I and II disorders: A 5-year follow-up study,” Bipolar Disorders, 2017: 19: 13-22.

© 2016 NeuroRx, Inc.

*These drugs are investigational and not approved by the US FDA

STAY CONNECTED